… Additionally, after treatment, levels of liver function, cirrhosis, blood coagulation function
and splenomegaly in the treated group were all improved significantly (P<0.05 or P<0.01), and …

… of abnormal hepatic function. The abdominal MRI showed liver cirrhosis and high signal …
性纤维化跨膜传导 调节因子(cystic fibrosis transmembrane conductance regulator,CFTR)基因…

… One hundred twenty-one patients without obvious basal liver disease or DM were included
in the group with cryptogenic HCC, in whom liver cirrhosis because of NASH or NAFLD may …

… Results: In DMN liver fibrosis model, hepatic fibrosis was obvious at week 2 and cirrhosis
was … Compared to 6-week DMN group, hepatic pathological changes and liver function were …

… infections, alcoholic cirrhosis, dietary exposure to aflatoxin, and other causes of chronic liver
disease." HCC metastasizes commonly to the lungs, causing tumor pulmonary emboli and …

… liver diseases such as fatty liver disease, liver cirrhosis, hepatitis, etc. Insulin resistance not
only participates in the development of chronic liver diseases … to chronic liver diseases based …

… Abstract: Cirrhosis is the most common cause of portal … ; other, less frequent non-cirrhotic
liver disease and other systemic disease causes are therefore grouped as non-cirrhotic portal …

… Non-alcoholic fatty liver disease (NAFLD) is one of the most common forms of chronic liver
disease, ranging from fatty liver to non-alcoholic steatohepatitis and cirrhosis. Inflammation …

… autoimmune hepatitis and primary biliary cirrhosis overlap syndrome. … of Chinese medicine
treatment of pulmonary fibrosis [J]. … for overlap syndromes of autoimmune liver diseases [J]. …

… , DMN model group showed liver damage and liver fibrosis, with remarkably increased Hyp
content (P<0.01) and abnormal liver function (P<0.01). Liver fibrosis induced by DMN in rats …